Patients harboring epidermal growth factor receptor (EGFR) double mutations had a lower objective response rate than those with a single mutation in non-small cell lung cancer when treated with EGFR-tyrosine kinase inhibitors

The quantitatively analysis of epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer (NSCLC) and its correlation with response rate of EGFR tyrosine kinase inhibitors (TKI)

10.1158/diag-10-pr10 ◽

2010 ◽

Cited By ~ 1

Author(s):

Jun Li ◽

Zhao Chen ◽

Daqiang Sun ◽

Meilin Xu ◽

Xun Zhang ◽

...

Keyword(s):

Lung Cancer ◽

Kinase Inhibitors ◽

Response Rate ◽

Growth Factor Receptor ◽

Small Cell ◽

Egfr Mutations ◽

Small Cell Lung ◽

Tumor heterogeneity affects the activity of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in EGFR mutant non-small cell lung cancer (NSCLC) patients (pts)

Annals of Oncology ◽

10.1093/annonc/mdw332.03 ◽

2016 ◽

Vol 27 ◽

pp. iv4

Author(s):

N. Normanno ◽

A.M. Rachiglio ◽

M. Lambiase ◽

F. Fenizia ◽

A. Iannaccone ◽

...

Keyword(s):

Lung Cancer ◽

Tumor Heterogeneity ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Epidermal Growth ◽

Egfr Mutant ◽

Nsclc Patients

Expression of insulin-like growth factor 1 receptor (IGF-1R) predicts poor responses to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in non-small cell lung cancer patients harboring activating EGFR mutations

Lung Cancer ◽

10.1016/j.lungcan.2015.01.004 ◽

2015 ◽

Vol 87 (3) ◽

pp. 311-317 ◽

Cited By ~ 31

Author(s):

Chang Dong Yeo ◽

Ki Hoon Park ◽

Chan Kwon Park ◽

Sang Haak Lee ◽

Seung Joon Kim ◽

...

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Small Cell ◽

Egfr Mutations ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Uncommon epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer and sensitivity to EGFR tyrosine kinase inhibitors, a two centers experience

Annals of Oncology ◽

10.1093/annonc/mdw332.20 ◽

2016 ◽

Vol 27 ◽

pp. iv9

Author(s):

M. Bonomi ◽

L. Bonomi ◽

M.G. Sauta ◽

A.C. Bettini ◽

M. Squadroni ◽

...

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Small Cell ◽

Egfr Mutations ◽

Small Cell Lung ◽

Uncommon mutation types of epidermal growth factor receptor and response to EGFR tyrosine kinase inhibitors in Chinese non-small cell lung cancer patients

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-017-3464-9 ◽

2017 ◽

Vol 80 (6) ◽

pp. 1179-1187 ◽

Cited By ~ 7

Author(s):

Kaiyan Chen ◽

Xiaoqing Yu ◽

Haiyang Wang ◽

Zhiyu Huang ◽

Yanjun Xu ◽

...

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Tumor heterogeneity affects the activity of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in EGFR mutant non-small cell lung cancer (NSCLC) patients (pts)

Annals of Oncology ◽

10.1093/annonc/mdw383.35 ◽

2016 ◽

Vol 27 ◽

pp. vi427

Author(s):

N. Normanno ◽

A.M. Rachiglio ◽

M. Lambiase ◽

F. Fenizia ◽

A. Iannaccone ◽

...

Keyword(s):

Lung Cancer ◽

Tumor Heterogeneity ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Epidermal Growth ◽

Egfr Mutant ◽

Nsclc Patients

Making progress in epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer by surpassing resistance: third-generation EGFR tyrosine kinase inhibitors (EGFR-TKIs)

Annals of Translational Medicine ◽

10.21037/atm.2017.10.04 ◽

2018 ◽

Vol 6 (8) ◽

pp. 140-140 ◽

Cited By ~ 8

Author(s):

Giannis Mountzios

Keyword(s):

Lung Cancer ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Small Cell ◽

Third Generation ◽

Small Cell Lung ◽

Epidermal Growth ◽

Egfr Mutant ◽

Egfr Tkis

Primary resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in patients with non-small-cell lung cancer harboring TKI-sensitive EGFR mutations: an exploratory study

Annals of Oncology ◽

10.1093/annonc/mdt127 ◽

2013 ◽

Vol 24 (8) ◽

pp. 2080-2087 ◽

Cited By ~ 61

Author(s):

J.K. Lee ◽

J.-Y. Shin ◽

S. Kim ◽

S. Lee ◽

C. Park ◽

...

Keyword(s):

Lung Cancer ◽

Exploratory Study ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Small Cell ◽

Egfr Mutations ◽

Small Cell Lung ◽

Primary Resistance ◽

Epidermal growth factor receptor (EGFR) exon 20 mutations in non-small-cell lung cancer and resistance to EGFR-tyrosine kinase inhibitors

Investigational New Drugs ◽

10.1007/s10637-014-0146-x ◽

2014 ◽

Vol 32 (6) ◽

pp. 1311-1315 ◽

Cited By ~ 16

Author(s):

Hyun Sun Woo ◽

Hee Kyung Ahn ◽

Ha Yeon Lee ◽

Inkeun Park ◽

Young Saing Kim ◽

...

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Epidermal Growth ◽

Exon 20

A combined subtype of small cell lung cancer and adenocarcinoma with epidermal growth factor receptor (EGFR) mutation responds to EGFR tyrosine kinase inhibitors

Journal of Thoracic Disease ◽

10.21037/jtd.2018.09.101 ◽

2018 ◽

Vol 10 (10) ◽

pp. E739-E743

Author(s):

Yong Zhang ◽

Ling Ye ◽

Huijun Zhang ◽

Xuehua Chen ◽

Haiying Ji ◽

...

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Kinase Inhibitors ◽

Egfr Mutation ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽